These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3054689)

  • 1. The use of amide local anesthetics in patients susceptible to malignant hyperthermia.
    Minasian A; Yagiela JA
    Oral Surg Oral Med Oral Pathol; 1988 Oct; 66(4):405-15. PubMed ID: 3054689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide local anaesthetics and malignant hyperthermia.
    Paasuke RT; Brownell AK
    Can Anaesth Soc J; 1986 Mar; 33(2):126-9. PubMed ID: 3697809
    [No Abstract]   [Full Text] [Related]  

  • 3. Myotoxicity of local anesthetics is equivalent in individuals with and without predisposition to malignant hyperthermia.
    Otsuki S; Yasuda T; Mukaida K; Noda Y; Kanzaki R; Miyoshi H; Kondo T; Hamada H; Kawamoto M
    J Anesth; 2018 Aug; 32(4):616-623. PubMed ID: 29938387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local anesthesia and malignant hyperthermia: review of the literature and recommendations for the dermatologic surgeon.
    Murray C; Sasaki SS; Berg D
    Dermatol Surg; 1999 Aug; 25(8):626-30. PubMed ID: 10491046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TENS-induced pain control in a malignant hyperthermia-susceptible patient.
    Stenberg W
    Anesth Prog; 1994; 41(4):100-1. PubMed ID: 8934960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Registration of peranesthetic cases of malignant hyperthermia in France. An update].
    Jacquot C; Stieglitz P; Kozak-Reiss G; Krivosic-Horber R; Laxenaire MC; Lienhart A; Nivoche Y
    Ann Fr Anesth Reanim; 1988; 7(6):524-34. PubMed ID: 3223647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of amide local anesthetics in patients susceptible to malignant hyperthermia.
    Dershwitz M; Ryan JF; Guralnick W
    J Am Dent Assoc; 1989 Mar; 118(3):276, 278, 280. PubMed ID: 2646341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia.
    Taiclet L
    Anesth Prog; 1985; 32(4):140-2. PubMed ID: 3865561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
    Mortier W; Breucking E
    Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single-Center Retrospective Review of Patients with Suspected Malignant Hyperthermia Susceptibility.
    Edwards C; Dooley FC; Gonzalez S; Austin TM; Gravenstein N
    Cureus; 2023 Sep; 15(9):e44661. PubMed ID: 37799222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmed allergic reactions to amide local anesthetics.
    Seng GF; Kraus K; Cartwright G; Nerone R; Pacione R
    Gen Dent; 1996; 44(1):52-4. PubMed ID: 8940570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphologic examination of skeletal muscle preparations does not differentiate between malignant hyperthermia-susceptible and -normal patients.
    von Breunig F; Wappler F; Hagel C; von Richthofen V; Fiege M; Weisshorn R; Stavrou D; Schulte am Esch J
    Anesthesiology; 2004 Apr; 100(4):789-94. PubMed ID: 15087612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical protocol by habit--the avoidance of amide local anesthetics in malignant hyperthermia susceptible patients.
    Adragna MG
    Anesthesiology; 1985 Jan; 62(1):99-100. PubMed ID: 3966683
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the use of local anesthetics in the dental treatment of patients who are susceptible to malignant hyperthermia.
    D'Ambrosio J; Adragna MG
    Spec Care Dentist; 1988; 8(2):61-3. PubMed ID: 2978768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale].
    von Richthofen V; Wappler F; Scholz J; Fiege M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):244-9. PubMed ID: 9617423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
    Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
    J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia. Report of two cases.
    Krakowiak FJ; Vatral JJ; Moore RC; Pickett AB; Nylander JE; Gullett FC
    Oral Surg Oral Med Oral Pathol; 1979 Mar; 47(3):218-22. PubMed ID: 283351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.